Levita Magnetics today announced the international launch of its MARS (magnetic-assisted robotic surgery) system with its placement at Hospital Luis Tisne in Santiago, Chile. Dr. Julio Jimenez used the system to perform same-day-discharge cholecystectomies (gallbladder removal) and bariatric surgeries. Jiminez previously helped Levita Magnetics with its clinical trials, said Levita Magnetics founder, CEO and President […]
Urology
Bright Uro raises $23M Series A to support urodynamics system
Bright Uro announced today that it closed $23 million in a Series A funding round to support its Glean urodynamics system. Irvine, California–based Bright Uro plans to use the funding to help garner FDA 510(k) clearance for Glean. It set its sights on a U.S. launch for the product in 2024. Glean, a comprehensive system, […]
Boston Scientific wins FDA approval for penile prosthesis pump
Boston Scientific announced that the FDA granted approval for its Tenacio pump component for its AMS 700 inflatable penile prosthesis (IPP). The AMS 700 IPP offers a treatment option for patients with erectile dysfunction. It features three parts. The system has a pair of cylinders implanted in the penis, a pump placed in the scrotum […]
Laborie acquires drug-coated balloon maker Urotronic
Laborie Medical Technologies announced today that it completed the acquisition of drug-coated balloon developer Urotronic. The companies struck an agreement last month for Laborie to buy Urotronic for up to $600 million. Urotronic developed the Optilume DCB used in interventional urology procedures. It treats urethral strictures and benign prostatic hyperplasia (BPH) or enlarged prostate conditions. […]
Teleflex completes Palette Life Sciences acquisition
Teleflex (NYSE: TFX) this week completed the previously announced acquisition of Palette Life Sciences. The Wayne, Pennsylvania-based company first announced the acquisition in July. Under the terms of the agreement, Teleflex bought Palette for an upfront cash payment of $600 million at closing, with additional consideration of up to $50 million upon the achievement of […]
UroMems completes first-in-human study enrollment for smart urinary implant
UroMems announced today that it successfully completed enrollment in its first-in-human study of its UroActive system. Grenoble, France-based UroMems designed the UroActiv system as a smart, automated artificial urinary sphincter (AUS). It treats stress urinary incontinence (SUI). Results from the initial study should support the design and implementation of a pivotal trial in Europe and […]
FDA grants de novo nod to BlueWind Medical’s neuromod for urinary incontinence
BlueWind Medical announced today that the FDA granted a de novo marketing request for its Revi neuromodulation system. Park City, Utah-based BlueWind designed Revi as a tibial neuromodulation system for treating the symptoms of incontinence. It treats urgency incontinence alone or in combination with urinary urgency. De novo approval for men and women with urge […]
Teleflex to acquire Palette Life Sciences to boost its urology portfolio
Teleflex announced today that it entered into a definitive agreement to acquire Palette Life Sciences. The deal to acquire the privately-held urology technology developer includes an upfront cash payment of $600 million at closing. It also includes up to an additional $50 million upon the achievement of certain commercial milestones. Wayne, Pennsylvania-based Teleflex said in […]
Study backs Olympus iTind for treating enlarged prostate
Olympus today announced positive study data for its minimally invasive iTind treatment for symptoms of enlarged prostate. The iTind procedure involves the placement of a temporary implanted nitinol device that reshapes the prostatic urethra. It does this without burning or cutting the prostate. Device placement can occur in an outpatient setting or physician’s office. The […]
FDA approves drug-coated balloon for BPH symptoms from Urotronic
Urotronic announced that the FDA approved its Optilume BPH catheter system for to alleviate urinary symptoms caused by BPH. Minneapolis-based Urotronic designed Optilume as a minimally invasive surgical therapy. It combines mechanical dilation using a proprietary double-lobe balloon with concurrent localized delivery of paclitaxel. This treats lower urinary tract symptoms secondary to BPG (benign prostatic […]
Smart implant from UroMems meets primary endpoint in first-in-human study
UroMems announced that it successfully met the primary endpoints for the initial male patient in a study of its UroActive smart implant. Grenoble, France-based UroMems develops mechatronics technology to treat stress urinary incontinence (SUI). Its SOPHIA study evaluates the UroActive smart, automated artificial urinary sphincter (AUS) in the treatment of SUI. The company plans for […]
